title: Response to letter regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy".
authors: Ziad
authors: Z
authors: Hijazi
authors: Jonas
authors: J
authors: Oldgren
authors: Lars
authors: L
authors: Wallentin
authors: Ulrika
authors: U
authors: Andersson
authors: Stuart J
authors: SJ
authors: Connolly
authors: Salim
authors: S
authors: Yusuf
authors: Michael D
authors: MD
authors: Ezekowitz
authors: Stefan H
authors: SH
authors: Hohnloser
authors: Paul A
authors: PA
authors: Reilly
authors: Dragos
authors: D
authors: Vinereanu
authors: Agneta
authors: A
authors: Siegbahn
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000097:blood* / Q000401:mortality*; D005260:Female; D006801:Humans; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D020521:Stroke / Q000097:blood* / Q000401:mortality*; D019210:Troponin I / Q000097:blood*
chemical_list: D000925:Anticoagulants; D010446:Peptide Fragments; D019210:Troponin I; D020097:Natriuretic Peptide, Brain